Pharmaceutical intermediates
Ozenoxacin Intermediates
3 pharmaceutical intermediates for Ozenoxacin. Indication: Infectious skin diseases; Furuncle; Acne vulgaris.
About Ozenoxacin
- Originator
- Takayama Chemical Co., Ltd
- Indication
- Infectious skin diseases; Furuncle; Acne vulgaris
- Approved Date
- 12/11/2017
- DS/DP
- 12/15/2027
Available intermediates
3 intermediates currently listed for Ozenoxacin. Request specifications, documentation or a quotation for any item below.
| Product Name | CAS No. | Molecular Formula | Physical Properties |
|---|---|---|---|
| ethyl 7-chloro-8-methyl-4-oxo-1,4-dihydroquinoline-3-carboxylate | 103877-51-6 | / | / |
| 5-broMo-N,3-diMethylpyridin-2-aMine | 245765-66-6 | / | / |
| [6-[benzoyl(methyl)amino]-5-methyl-3-pyridyl]boronic acid | 446299-81-6 | / | / |
Other programs under O
Building toward Ozenoxacin?
Tell us the step you need covered and the specification you are filing against. We will confirm supply, documentation and lead time.
How can we help you?
Receive insights into the latest events and regulatory updates
Sent directly to your email
Get industry insights and Unibest news here
Contact Us →